The primary goal of UniVenture is to support the development and implementation of marketable UM/MUMC+ knowledge and Intellectual Property. Thus far UniVenture has (directly and indirectly) invested in over 50 companies. Shares in a company are typically sold to a commercial party after 5-7 years. We currently hold equity in over 30 spin-off companies from Maastricht University and Maastricht University Medical Center.